Prediction Model of Gonadotropin Starting Dose and Its Clinical Application in Controlled Ovarian Stimulation

Overview

Journal BMC Pregnancy Childbirth

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2022 Nov 5

PMID 36333671

Authors

Liang Hua

Yang Zhe

Yang Jing

Shen Fujin

Chen Jiao

Liu Liu

Affiliations

Soon will be listed here.

Abstract

Background: Selecting an appropriate and personalized Gn starting dose (GSD) is an essential procedure for determining the quality and quantity of oocytes in the controlled ovarian stimulation (COS) process of the in-vitro fertilization (IVF) treatment cycle. The current approach for determining the GSD is mainly based on the experience of a clinician, lacking unified and scientific standards. This study aims to establish a prediction model of GSD, based on which good COS outcomes can be achieved with the influencing factors comprehensively evaluated quantitatively.

Material And Methods: We collected a total of 1555 patients undergoing the first oocytes retrieving cycle and conducted correlation analysis to find the significant factors related to the GSD. Two GSD models are built based on two popular machine learning approaches, and the one with better model performance is selected as the final model. Finally, clinical application and validation were conducted to verify the effectiveness of the proposed model.

Results: (1) Age, duration of infertility, type of infertility, body mass index (BMI), antral follicle count (AFC), basal follicle stimulating hormone (bFSH), estradiol (E), luteinizing hormone (LH), anti-Müllerian hormone (AMH) and COS treatment regimen were closely related to the GSD (P < 0.05). (2) The selected model has good modeling performance in terms of both root mean square error (RMSE) (29.87 ~ 34.21) and regression coefficient R (0.947 ~ 0.953). (3) A comprehensive evaluation of influencing factors for GSD is conducted and shows that the top four most significant factors are age, AMH, AFC, and BMI. (4) The proposed GSD can approximate the actual value well in the clinical application, with the mean absolute error of only 11.26 units, and the recommended results can prompt the number of oocytes retrieved (NOR) close to the optimal number.

Conclusion: Modeling the GSD value with machine learning approaches is feasible and effective, and the proposed model has good clinical application for determining the GSD in the IVF treatment cycle.

Citing Articles

Clinical data-based modeling of IVF live birth outcome and its application.

Liu L, Liang H, Yang J, Shen F, Chen J, Ao L Reprod Biol Endocrinol. 2024; 22(1):76.

PMID: 38978032 PMC: 11229224. DOI: 10.1186/s12958-024-01253-3.

Harnessing Artificial Intelligence to Predict Ovarian Stimulation Outcomes in In Vitro Fertilization: Scoping Review.

AlSaad R, Abd-Alrazaq A, Choucair F, Ahmed A, Aziz S, Sheikh J J Med Internet Res. 2024; 26:e53396.

PMID: 38967964 PMC: 11259766. DOI: 10.2196/53396.

Analysis of controlled ovarian hyperstimulation protocols in women over 35 years old with poor ovarian response: a real-world study.

Duan X, Li Z, Li M, Ma X BMC Pregnancy Childbirth. 2023; 23(1):813.

PMID: 37996795 PMC: 10666416. DOI: 10.1186/s12884-023-06112-4.

Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment.

Liu Y, Lin J, Shen X, Zhu Q, Kuang Y Front Endocrinol (Lausanne). 2023; 14:1072170.

PMID: 36936138 PMC: 10020617. DOI: 10.3389/fendo.2023.1072170.

References

McIlveen M, Skull J, Ledger W . Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Hum Reprod. 2006; 22(3):778-85. DOI: 10.1093/humrep/del435. View

Zhu M, Wang S, Yi S, Huang X, Meng J, Chen L . A predictive formula for selecting individual FSH starting dose based on ovarian reserve markers in IVF/ICSI cycles. Arch Gynecol Obstet. 2019; 300(2):441-446. DOI: 10.1007/s00404-019-05156-2. View

Keane K, Cruzat V, Wagle S, Chaudhary N, Newsholme P, Yovich J . Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome. Reprod Biol. 2017; 17(1):51-59. DOI: 10.1016/j.repbio.2016.12.002. View

Yan S, Jin W, Ding J, Yin T, Zhang Y, Yang J . Machine-intelligence for developing a potent signature to predict ovarian response to tailor assisted reproduction technology. Aging (Albany NY). 2021; 13(13):17137-17154. PMC: 8312467. DOI: 10.18632/aging.203032. View

La Marca A, Argento C, Sighinolfi G, Grisendi V, Carbone M, DIppolito G . Possibilities and limits of ovarian reserve testing in ART. Curr Pharm Biotechnol. 2011; 13(3):398-408. DOI: 10.2174/138920112799361972. View

Lehner A, Kaszas Z, Murber A, Rigo Jr J, Urbancsek J, Fancsovits P . Embryo density may affect embryo quality during in vitro culture in a microwell group culture dish. Arch Gynecol Obstet. 2017; 296(2):345-353. DOI: 10.1007/s00404-017-4403-z. View

Richardson S, Senikas V, NELSON J . Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab. 1987; 65(6):1231-7. DOI: 10.1210/jcem-65-6-1231. View

Sunkara S, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A . Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011; 26(7):1768-74. DOI: 10.1093/humrep/der106. View

Louis C, Erwin A, Handayani N, Polim A, Boediono A, Sini I . Review of computer vision application in in vitro fertilization: the application of deep learning-based computer vision technology in the world of IVF. J Assist Reprod Genet. 2021; 38(7):1627-1639. PMC: 8324729. DOI: 10.1007/s10815-021-02123-2. View

10.

Rustamov O, Wilkinson J, La Marca A, Fitzgerald C, Roberts S . How much variation in oocyte yield after controlled ovarian stimulation can be explained? A multilevel modelling study. Hum Reprod Open. 2019; 2017(3):hox018. PMC: 6276674. DOI: 10.1093/hropen/hox018. View

11.

Pouly J, Olivennes F, Massin N, Celle M, Caizergues N, Contard F . Usability and utility of the CONSORT calculator for FSH starting doses: a prospective observational study. Reprod Biomed Online. 2015; 31(3):347-55. DOI: 10.1016/j.rbmo.2015.06.001. View

12.

Howles C, Saunders H, Alam V, Engrand P . Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An.... Curr Med Res Opin. 2006; 22(5):907-18. DOI: 10.1185/030079906X104678. View

13.

Scheffer J, Scheffer B, Carvalho R, Rodrigues J, Grynberg M, Lozano D . Age as A Predictor of Embryo Quality Regardless of The Quantitative Ovarian Response. Int J Fertil Steril. 2017; 11(1):40-46. PMC: 5215710. DOI: 10.22074/ijfs.2016.4579. View

14.

van Montfoort A, Arts E, Wijnandts L, Sluijmer A, Pelinck M, Land J . Reduced oxygen concentration during human IVF culture improves embryo utilization and cumulative pregnancy rates per cycle. Hum Reprod Open. 2020; 2020(1):hoz036. PMC: 6975868. DOI: 10.1093/hropen/hoz036. View

15.

Loy S, Cheung Y, Fortier M, Ong C, Tan H, Nadarajah S . Age-related nomograms for antral follicle count and anti-Mullerian hormone for subfertile Chinese women in Singapore. PLoS One. 2017; 12(12):e0189830. PMC: 5730199. DOI: 10.1371/journal.pone.0189830. View

16.

Fleming R, Deshpande N, Traynor I, Yates R . Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone. Hum Reprod. 2006; 21(6):1436-41. DOI: 10.1093/humrep/dei499. View

17.

Farquhar C, Marjoribanks J . Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2018; 8:CD010537. PMC: 6953328. DOI: 10.1002/14651858.CD010537.pub5. View

18.

Revelli A, Gennarelli G, Biasoni V, Chiado A, Carosso A, Evangelista F . The Ovarian Sensitivity Index (OSI) Significantly Correlates with Ovarian Reserve Biomarkers, Is More Predictive of Clinical Pregnancy than the Total Number of Oocytes, and Is Consistent in Consecutive IVF Cycles. J Clin Med. 2020; 9(6). PMC: 7355532. DOI: 10.3390/jcm9061914. View

19.

Daya S . Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev. 2000; (2):CD001299. PMC: 10734377. DOI: 10.1002/14651858.CD001299. View

20.

Popovic-Todorovic B, Loft A, Lindhard A, Bangsboll S, Andersson A, Nyboe Andersen A . A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod. 2003; 18(4):781-7. DOI: 10.1093/humrep/deg181. View